Illumina partners with D3b to analyze 100,000 pediatric genomes
Illumina (NASDAQ: ILMN) announced a data partnership with the Center for Data-Driven Discovery in Biomedicine to advance pediatric cancer and ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
